Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ACT GEMCITABINE - Health Canada Drug Approval Details

Approvals/Health Canada/ACT GEMCITABINE

Authorized

STANDARD

ACT GEMCITABINE

actavis pharma company🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: d7f04775fe730651
Company: actavis pharma company
Type: Standard

Approval Details

Approval Id: d7f04775fe730651
Drug Approval Canada Name: ACT GEMCITABINE
Product Name: ACT GEMCITABINE
Status: Cancelled Post Market
Status Date: 2019-08-13
Original Market Date: 2016-05-02
Din: 02433117
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01BC05 GEMCITABINE
Atc Name: l 01 bc 05
Aig Number: 0133122005
Company Name: actavis pharma company
Company Address: 30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9

Active Ingredients

GEMCITABINE (GEMCITABINE HYDROCHLORIDE)

38 MG / ML

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d7f04775fe730651

Type

Standard

Back to Health Canada Approvals